Delphi has posted a third quarter net loss of $US1.2bn on revenues of $6.2bn. The net loss for the first nine months of 2007 was $2.5bn compared to $4.6bn a year ago.
Non-GM revenues were $3.6bn, or 58%, up 5% from $3.4bn a year ago, primarily due to favourable foreign currency exchange, volumes and mix.
The net loss included an accrual of $369m for interest expense on prepetition claims in Delphi’s plan of reorganisation filed with the Bankruptcy Court, charges of $244m for US employee workforce transition programmes ($1.0bn a year ago), $124m for charges for warranty matters and $112m of employee termination benefits and other exit costs.
Included in the first nine months of 2007 net loss ($2.5bn) were charges of $532m in employee termination benefits and other exit costs, $369m related to interest expense on prepetition claims, $353m related to the Securities and ERISA litigation settlement, $264m of charges for warranty matters, $238m in US employee workforce transition charges and $222m in long-lived asset impairment charges.
Global revenue of $19.9bn was virtually flat from $20.0bn in first nine months of 2006.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataGM revenue for first nine months of 2007 was down about 7% to $8.3bn, due primarily due to reductions in GM North America production and the wind-down of some programmes.
Non-GM revenue was up about 5% to $11.6bn primarily due to favourable currency exchange rates. Non-GM revenue accounted for 58% of first nine months of 2007 revenues, compared to year-ago levels of 56%.